The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Questcor Pharmaceuticals (QCOR) and Announces Investigations of Assisted Living Concepts (ALC), Blyth (BTH), Cymer (CYMI), Feihe International (NYSE: ADY), OCZ Technology Group (OCZ), Peregrine Pharmaceuticals (PPHM) and Union Drilling (UDRL)

Monday, October 22, 2012

Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Questcor Pharmaceuticals (QCOR) and Announces Investigations of Assisted Living Concepts (ALC), Blyth (BTH), Cymer (CYMI), Feihe International (NYSE: ADY), OCZ Technology Group (OCZ), Peregrine Pharmaceuticals (PPHM) and Union Drilling (UDRL)14:27 EDT Monday, October 22, 2012PITTSBURGH, Oct. 22, 2012 /PRNewswire/ -- Notice is hereby given by the Law Office of Alfred G. Yates Jr., P.C. that it has filed a class action in the United States District Court for the Central District of California on behalf of purchasers of Questcor Pharmaceuticals, Inc. ("Questcor") (Nasdaq: QCOR) securities during the period between April 4, 2011 and September 21, 2012 (the "Class Period").   If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff's counsel, Alfred G. Yates Jr., Esquire at 1-800-391-5164, toll free, or at yateslaw@aol.com by e-mail. Please visit http://yatesclassactionlaw.com for more information. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. If you wish to serve as lead plaintiff, you must move the Court no later than November 26, 2012.The complaint charges Questcor and certain of its officers and directors with violations of the Securities Exchange Act of 1934.  The complaint alleges that throughout the Class Period, defendants violated the federal securities laws by disseminating false and misleading statements to the investing public about the effectiveness of Acthar as a treatment for MS and nephrotic syndrome, making it impossible for shareholders to gain a meaningful or realistic understanding of the drug's prospects and market success.  As a result of defendants' false statements, Questcor's stock traded at artificially inflated prices during the Class Period, reaching a high of $57.64 per share on July 9, 2012.Plaintiff seeks to recover damages on behalf of all purchasers of Questcor securities during the Class Period (the "Class").The firm is also investigating actions on behalf of shareholders for the following companies: Assisted Living Concepts, Inc. (NYSE: ALC), Blyth, Inc. (NYSE: BTH), Cymer, Inc. (Nasdaq: CYMI), Feihe International, Inc. (NYSE: ADY), OCZ Technology Group, Inc. (Nasdaq: OCZ), Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) and Union Drilling, Inc. (Nasdaq: UDRL).If you are a shareholder of any of the above companies and wish learn more about any of the investigations or have any questions, please contact Alfred G. Yates Jr., Esquire at 1-800-391-5164, toll free, or at yateslaw@aol.com by e-mail.Contact:Alfred G. Yates, Jr.(412) 391-5164 or Toll Free: 1(800) 391-5164, fax (412) 471-1033website: http://yatesclassactionlaw.com email: yateslaw@aol.com  SOURCE Law Office of Alfred G. Yates Jr., P.C.